# Processa Pharmaceuticals, Inc.: Form 8-K, filed Aug 8, 2025

- Company: [Processa Pharmaceuticals, Inc.](/companies/pcsa.md) (CIK 1533743)
- Form: 8-K
- Filed: 2025-08-08
- Accepted by EDGAR: Aug 8, 2025, 17:17 ET
- Period: 2025-08-07
- Accession: 0001493152-25-011775
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1533743/000149315225011775/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1533743/000149315225011775/

## Items reported

- Item 3.01: Delisting notice
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1533743/000149315225011775/form8-k.htm

Filed Aug 8, 2025.
Source: SEC EDGAR, the filing index for accession 0001493152-25-011775. Last ingested by Listed: Nov 5, 2026, 12:19 ET. No prices; not investment advice.